Smoking cessation program impacts on mortality and hospitalizations for cardiovascular diseases
DOI:
https://doi.org/10.17058/reci.v15i3.20209Keywords:
Hospitalization, Mortality, Tobacco , Cardiovascular DiseasesAbstract
Background and Objectives: Smoking is an important risk factor for CVD. Tobacco use is associated with health system expenditures and loss of life expectancy and quality of life. Brazil has a tobacco control program and has shown a continuous decline in prevalence. This study verified whether the decrease in smoking prevalence was reflected in mortality and hospitalizations due to CVD, comparing with the same variables for RTD. Methods: The period 2006-2023 was divided into six triennia. Data on smoking prevalence, population, and mortality and hospitalizations due to CVD and RTD were extracted from VIGITEL, IBGE, and DATASUS. The Rstudio software, version 4.1.2, was used to perform the linear regression model and the correlation test. Results: Prevalence tended to decrease in Brazil and its regions, except for the Midwest. Mortality and hospitalization rates per 100,000 inhabitants showed an upward trend in Brazil. Hospitalizations due to RTD showed a strong downward trend, with only the South showing stability. There was no positive correlation between the prevalence of smoking and the variables mortality rate and hospitalizations per 100,000 due to CVD, while there was a strong positive correlation for hospitalizations due to RTD. Conclusion: The participation of other risk factors in mortality and hospitalizations due to CVD should be investigated and awareness campaigns about smoking should be expanded. The tobacco control program is an example of a successful public policy.
Downloads
References
1. Oliveira GMM de, Brant LCC, Polanczyk CA, et al. Estatística Cardiovascular – Brasil 2021. Arq Bras Cardiol. 19 de janeiro de 2022;118(1):115–373. https://doi.org/10.36660/abc.20211012
2. Malta DC, Flor LS, Machado ÍE, et al. Trends in prevalence and mortality burden attributable to smoking, Brazil and federated units, 1990 and 2017. Popul Health Metr. setembro de 2020;18(S1):24. https://doi.org/10.1186/s12963-020-00215-2
3. Reitsma MB, Kendrick PJ, Ababneh E, et al. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet. junho de 2021;397(10292):2337–60. https://doi.org/10.1016/S0140-6736(21)01169-7
4. Wanderley-Flores B, Pérez-Ríos M, Montes A, et al. Mortalidad atribuida al consumo de tabaco en Brasil, 1996-2019. Gac Sanit. 2023;37:102297. https://doi.org/10.1016/j.gaceta.2023.102297
5. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Estimativa 2023: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2022. https://www.inca.gov.br/publicacoes/livros/estimativa-2023-incidencia-de-cancer-no-brasil
6. Pinto MT, Pichon-Riviere A, Bardach A. Estimativa da carga do tabagismo no Brasil: mortalidade, morbidade e custos. Cad Saúde Pública. junho de 2015;31:1283–97. https://doi.org/10.1590/0102-311X00192013
7. World Health Organization (WHO). WHO report on the global tobacco epidemic, 2019: offer help to quit tobacco use. Geneva: WHO; 2019. 121 p. ISBN: 978-92-4-151620-4. https://www.who.int/publications/i/item/9789241516204
8. World Health Organization (WHO). Tobacco [Internet]. World Health Organization. World Health Organization; 2025. Disponível em: https://www.who.int/news-room/fact-sheets/detail/tobacco
9. Kondo T, Nakano Y, Adachi S, Murohara T. Effects of Tobacco Smoking on Cardiovascular Disease. Circ J. 25 de setembro de 2019;83(10):1980–5. https://doi.org/10.1253/circj.CJ-19-0323
10. Benowitz NL, Liakoni E. Tobacco use disorder and cardiovascular health. Addiction. abril de 2022;117(4):1128–38. https://doi.org/10.1111/add.15703
11. Guerra SIS, Vale JM, Nunes RD. Smoking cessation programme in hospitalised patients due to acute respiratory disease. Intern Med J. dezembro de 2022;52(12):2130–5. https://doi.org/10.1111/imj.15498
12. Sales MPU, Araújo AJD, Chatkin JM, et al. Update on the approach to smoking in patients with respiratory diseases. J Bras Pneumol. 2019;45(3):e20180314. https://doi.org/10.1590/1806-3713/e20180314
13. Serrano Gotarredona MP, Navarro Herrero S, Gómez Izquierdo L, Rodríguez Portal JA. Smoking-related interstitial lung disease. Radiologia. dezembro de 2022;64 Suppl 3:277–89. https://doi.org/10.1016/j.rxeng.2022.10.008
14. Portes LH, Machado CV, Turci SRB, Figueiredo VC, Cavalcante TM, Silva VLDCE. A Política de Controle do Tabaco no Brasil: um balanço de 30 anos. Ciênc Saúde Coletiva. junho de 2018;23(6):1837–48. https://doi.org/10.1590/1413-81232018236.05202018
15. Carvalho De Souza M, Giunta DH, Szklo AS, Almeida LMD, Szklo M. The tobacco epidemic curve in Brazil: Where are we going? Cancer Epidemiol. agosto de 2020;67:101736. https://doi.org/10.1016/j.canep.2020.101736
16. Santos LP, De Oliveira Meller F, Amann VR, Schäfer AA. Temporal trends in behavioral risk and protective factors and their association with mortality rates: results from Brazil and Argentina. BMC Public Health. dezembro de 2020;20(1):1390. https://doi.org/10.1186/s12889-020-09512-9
17. Ministério da Saúde. Vigitel Brasil 2006-2023: tabagismo e consumo abusivo de álcool. Brasília, DF: Ministério da Saúde; 2023. https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/vigitel/vigitel-brasil-2006-2023-tabagismo-e-consumo-abusivo-de-alcool
18. Wittkowski L, Dias CRS. Avaliação dos resultados obtidos nos grupos de controle do tabagismo realizados numa unidade de saúde de Curitiba-PR. Rev Bras Med Fam E Comunidade. 2017;12(39):1–11. https://doi.org/10.5712/rbmfc12(39)1463
19. Malta DC, Gomes CS, Andrade FMDD, et al. Tobacco use, cessation, secondhand smoke and exposure to media about tobacco in Brazil: results of the National Health Survey 2013 and 2019. Rev Bras Epidemiol. 2021;24(suppl 2):e210006. https://doi.org/10.1590/1980-549720210006.supl.2
20. Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. The Lancet. março de 2020;395(10226):795–808. https://doi.org/10.1016/S0140-6736(19)32008-2
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Emílio Augusto Andrade Borges, Erildo Vicente Muller , Camila Marinelli Martins, Ruann Oswaldo Carvalho da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.
